MADRIGAL PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Letter Agreement (including agreements attached as exhibits thereto), dated as of September 7, 2023, by and between Madrigal Pharmaceuticals, Inc. and William Sibold (Filed With SEC on September 13, 2023)
- Form of RSU Agreement for Employees (Filed With SEC on August 8, 2023)
- Form of RSU Agreement for Executive Officers (Filed With SEC on August 8, 2023)
- Form of RSU Agreement for Directors (Filed With SEC on August 8, 2023)
- Description of Securities of the Registrant (Filed With SEC on February 23, 2023)
- Description of Securities of the Registrant (Filed With SEC on February 26, 2020)
- [Madrigal Letterhead] (Filed With SEC on July 22, 2016)
- [Madrigal Letterhead] (Filed With SEC on July 22, 2016)
- LOCK-UP AGREEMENT (Filed With SEC on April 14, 2016)
- UPDATED OFFER LETTER (Filed With SEC on August 6, 2015)
- SYNTA PHARMACEUTICALS CORP. December 8, 2014 (Filed With SEC on March 12, 2015)
- SYNTA PHARMACEUTICALS CORP. December 8, 2014 (Filed With SEC on March 12, 2015)
- SYNTA PHARMACEUTICALS CORP. September 2, 2014 (Filed With SEC on November 6, 2014)
- Synta Pharmaceuticals Corp. 45 Hartwell Avenue Lexington, MA 02421 March 19, 2014 (Filed With SEC on March 20, 2014)
- 125 Hartwell Avenue Lexington, Massachusetts02421 (the Building) NINTH AMENDMENT May 19, 2009 (Filed With SEC on August 4, 2009)
- 125 Hartwell Avenue Lexington, Massachusetts 02421 (the Building) EIGHTH AMENDMENT June 19,2008 (Filed With SEC on August 7, 2008)
